Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. - Wikidata - wikimedia - TriplyDB

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

http://www.wikidata.org/entity/Q35791518

about

Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay Tumor cell plasticity and angiogenesis in human melanomas Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density.Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.Hepatocyte growth factor promotes lymphatic vessel formation and function.Up-regulated Dicer expression in patients with cutaneous melanoma Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.The lymphatic system in health and disease.Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.Cutaneous melanoma: prognostic factors.Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Generation of an effective anti-lung cancer vaccine by DTPP-mediated photodynamic therapy and mechanistic studies.Current concepts of metastasis in melanoma.High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis.The clinical impact of mean vessel size and solidity in breast carcinoma patients.Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors.Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.Molecular mechanisms in lymphangiogenesis: model systems and implications in human disease.Angiogenesis and melanoma - from basic science to clinical trials.Metastatic breast cancer cells in lymph nodes increase nodal collagen density.Lack of lymphangiogenesis during breast carcinogenesis LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.

P2860

Q24562741-D4A392F0-EC6B-4EE5-89CE-EC80DB26E373 Q24675750-590A44BE-9E09-4267-9596-2BB29FCC5F8F Q26778332-DC104903-4CAD-4FC4-88AB-D6B3FA1622D9 Q28242925-C54F03DB-67CF-4FEA-8323-44CBD3C6FA80 Q28484038-739B09F0-4E4C-4500-A7C5-473D76D11D59 Q30278005-851B7A65-75C3-48DB-9051-54E3DE75BC61 Q30836624-047D63F1-DCE3-49A1-A107-636C8BE38B7E Q31052984-2884A2C8-1664-45EE-8C26-8B1CF0FA431C Q33232622-AC3D7002-F4C7-48CD-8C82-B2880A1E20F5 Q33355483-88271729-605D-48B6-88EC-9FC54A7537F0 Q33550623-D59ADAD3-53D3-42B1-B440-F44945359983 Q33579590-9991767E-2062-46C7-AF2A-263D4C5C44F8 Q33651167-D745ED22-B1A1-44A1-B435-2DBF3F1856A8 Q33699388-1A39DBEA-3A56-46FF-B3A5-C3191D1B8D58 Q33714753-2BA9A6A9-8287-4A51-8AA4-D7C9D048FB3C Q33788042-C045358C-6DD7-4E06-A1B9-A92654641A89 Q33919993-C2753154-660F-444B-86DA-229F3A4165A1 Q33940775-D3A52243-D82F-4487-9D5A-1F1D2B2071BB Q33967503-901E0C6E-033A-494E-9FA5-7F7304349F04 Q33986146-360A7878-74D0-490A-8FB6-C55E5FF88C9D Q34015299-F2F0FE2F-25D1-4FDA-98DF-1CC4D4EABAD7 Q34277464-19EA56AE-7736-43D0-973C-8A6DA6A132A2 Q34403458-405FD86E-E371-447A-AB0F-2C6CA8DEF088 Q34406774-3D44C02A-3643-446F-9DBF-1E860116A69A Q34463933-0D47CA19-E765-492B-B53C-F621B7C2169E Q34600828-E52ED439-AA19-4104-9157-71E952CEBE1A Q34605795-0D0D1244-94B0-431E-99C3-BE66E8A0E2B5 Q34610427-23C11073-A36F-48EF-AF36-869BAD2ED12F Q34706205-7440F0C1-73A2-4C66-8867-3F3272070530 Q34781474-EB64D8F6-A06A-4BDC-981E-D872F9C3C32A Q34805427-A6044D3C-FAB1-4C1C-B2D4-90357CC2D196 Q35022553-4F83EAA0-6FC4-407D-B64C-9504B90B9397 Q35103259-597EDC2E-5F7D-4C83-A88A-1E362B5959D5 Q35171541-50B71CD3-ACD7-4C0D-AC7F-75427287A55D Q35219275-47B04364-3C82-420C-8FA6-32CADD7FE477 Q35380959-7AAD65BE-6752-459B-A4F4-D5A95DE1F1CE Q35580080-8820F11A-239A-41F4-B266-CD253B0A8087 Q35587730-9F33B5D2-9154-4002-B9E1-291F32A07D93 Q35588306-4BE81EEC-6FFE-4CBD-B51B-37ABDC802AC2 Q35588719-CB277B67-EA9F-40E5-BCE5-ABFFBBBBBD59

P2860

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

http://www.wikidata.org/entity/Q35791518

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@ast

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@en

type

label

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@ast

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@en

prefLabel

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@ast

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@en

P1433

Q35791518-017D7B17-C400-4C85-B290-69AD5E5E840F

P1476

Q35791518-EF44E951-BBC4-426B-B6E8-19A9F71089F3

P2093

Q35791518-3AEEEE21-3A65-4EC4-A85A-1E44734A92C9

Q35791518-3BCE6A8D-41BB-4E3E-8681-8234A147E0BE

Q35791518-60CE6981-93F6-444B-8882-66BEA53A507F

Q35791518-6E08944A-999B-420C-AA53-5EC0B134576D

Q35791518-748C2F09-6D4F-4CDD-988F-17E63BF88492

Q35791518-7B2C0567-53B9-47C0-AC7F-56FBCA6DED59

Q35791518-CE667CBB-9732-4504-9A98-150EDAC201E9

Q35791518-D4A88895-6CD8-486A-A0BB-386746A2651A

Q35791518-DF639012-4502-448B-A3A5-EE557C28EA5D

P2860

Q35791518-061406B0-52B5-45D4-B4AD-9F556F0C877F

Q35791518-0AAF05D7-789A-4131-B0A9-F7BAC58FE384

Q35791518-1062AFDE-1780-4F71-93B0-364F85050265

Q35791518-187646AE-DB77-4B29-9186-55A1F6973F3B

Q35791518-1C2B91D8-750F-4016-BE80-436A23AF4ADE

Q35791518-23976C50-7C98-4396-B0AA-02DF7F072050

Q35791518-293223C8-2A6F-47AE-840B-1FC7C4024A3F

Q35791518-2A953B00-39EF-4271-85F5-FFEE2FB108A4

Q35791518-31534603-0424-4250-BF65-FB9AD13C133D

Q35791518-44154CA6-3D6D-42B4-90D5-B1CD862A0B0D

P304

Q35791518-01652D62-B592-4E11-A37A-4DB8904CBA4B

P31

Q35791518-AEF1927E-AD64-4BBF-A8C5-284250D7C2D4

P356

Q35791518-5A551757-C4A9-4783-A241-2FF9F51E724E

P407

Q35791518-7C90113A-0111-4DC7-B99C-DB48D7F724AB

P433

Q35791518-DD9A436E-D26D-48A8-BCC7-A576FC2199EA

P478

Q35791518-CD5E56B7-7A12-4510-9B50-BBB8C35B9B15

P50

Q35791518-6D13082C-0ACA-4A70-A675-592CC1E0432B

P577

Q35791518-2EED30F3-380F-46BB-A96E-D8D0FE1D8C89

P698

Q35791518-B45AE498-26B7-4D12-B7B7-C644A1979B64

P921

Q35791518-F331498E-EF37-41D0-96ED-C0774F1D4973

P932

Q35791518-9B7535DF-4EAF-4C4D-9F81-8807D9ADF185

P356

S0002-9440(10)64328-3

P1433

The American Journal of Pathology

P1476

Tumor lymphangiogenesis: a nov ...... anoma metastasis and survival.

@en

P2093

Alona Muzikansky

http://www.w3.org/2001/XMLSchema#string

Claus Garbe

http://www.w3.org/2001/XMLSchema#string

David G Jackson

http://www.w3.org/2001/XMLSchema#string

Jennifer Bertoncini

http://www.w3.org/2001/XMLSchema#string

Lawrence F Brown

http://www.w3.org/2001/XMLSchema#string

Martin C Mihm

http://www.w3.org/2001/XMLSchema#string

Soheil S Dadras

http://www.w3.org/2001/XMLSchema#string

Thomas Paul

http://www.w3.org/2001/XMLSchema#string

Ulf Ellwanger

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

Angiogenesis in cancer and other diseases

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

Tumor progression, early diagnosis and prognosis of melanoma.

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

P304

1951-1960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64328-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12759251

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

1868148

http://www.w3.org/2001/XMLSchema#string